申请人:Zedira GmbH
公开号:EP3342779A1
公开(公告)日:2018-07-04
The invention relates to the compound of general formula (I) as novel inhibitors of transglutaminases, to methods for producing the inventive compounds, to pharmaceutical compositions containing said inventive compounds and to their use for the prophylaxis and treatment of diseases associated with transglutaminases.
这项发明涉及通式(I)的化合物作为新型转谷氨酰胺酶抑制剂,以及生产这些创新化合物的方法,含有这些创新化合物的药物组合物,以及它们用于预防和治疗与转谷氨酰胺酶相关疾病的用途。